18-51059974-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005359.6(SMAD4):​c.955+58C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0713 in 1,271,216 control chromosomes in the GnomAD database, including 3,562 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.054 ( 266 hom., cov: 32)
Exomes 𝑓: 0.074 ( 3296 hom. )

Consequence

SMAD4
NM_005359.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.748

Publications

23 publications found
Variant links:
Genes affected
SMAD4 (HGNC:6770): (SMAD family member 4) This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]
SMAD4 Gene-Disease associations (from GenCC):
  • juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, G2P, PanelApp Australia
  • Myhre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • generalized juvenile polyposis/juvenile polyposis coli
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • juvenile polyposis syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary hemorrhagic telangiectasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 18-51059974-C-T is Benign according to our data. Variant chr18-51059974-C-T is described in ClinVar as [Benign]. Clinvar id is 1253468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0792 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMAD4NM_005359.6 linkc.955+58C>T intron_variant Intron 8 of 11 ENST00000342988.8 NP_005350.1 Q13485A0A024R274

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMAD4ENST00000342988.8 linkc.955+58C>T intron_variant Intron 8 of 11 5 NM_005359.6 ENSP00000341551.3 Q13485

Frequencies

GnomAD3 genomes
AF:
0.0542
AC:
8234
AN:
151920
Hom.:
266
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0147
Gnomad AMI
AF:
0.0855
Gnomad AMR
AF:
0.0277
Gnomad ASJ
AF:
0.0476
Gnomad EAS
AF:
0.0447
Gnomad SAS
AF:
0.0487
Gnomad FIN
AF:
0.0858
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.0810
Gnomad OTH
AF:
0.0344
GnomAD4 exome
AF:
0.0737
AC:
82453
AN:
1119178
Hom.:
3296
AF XY:
0.0728
AC XY:
41680
AN XY:
572608
show subpopulations
African (AFR)
AF:
0.0114
AC:
304
AN:
26710
American (AMR)
AF:
0.0195
AC:
863
AN:
44170
Ashkenazi Jewish (ASJ)
AF:
0.0569
AC:
1365
AN:
23970
East Asian (EAS)
AF:
0.0437
AC:
1660
AN:
38006
South Asian (SAS)
AF:
0.0435
AC:
3435
AN:
79028
European-Finnish (FIN)
AF:
0.0864
AC:
4560
AN:
52796
Middle Eastern (MID)
AF:
0.0278
AC:
142
AN:
5104
European-Non Finnish (NFE)
AF:
0.0835
AC:
66811
AN:
800328
Other (OTH)
AF:
0.0675
AC:
3313
AN:
49066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4019
8038
12056
16075
20094
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2062
4124
6186
8248
10310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0541
AC:
8230
AN:
152038
Hom.:
266
Cov.:
32
AF XY:
0.0533
AC XY:
3959
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0147
AC:
609
AN:
41482
American (AMR)
AF:
0.0276
AC:
422
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.0476
AC:
165
AN:
3470
East Asian (EAS)
AF:
0.0443
AC:
229
AN:
5174
South Asian (SAS)
AF:
0.0488
AC:
235
AN:
4818
European-Finnish (FIN)
AF:
0.0858
AC:
905
AN:
10546
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0810
AC:
5507
AN:
67962
Other (OTH)
AF:
0.0341
AC:
72
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
414
829
1243
1658
2072
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0687
Hom.:
698
Bravo
AF:
0.0482
Asia WGS
AF:
0.0330
AC:
113
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.4
DANN
Benign
0.53
PhyloP100
-0.75
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs948588; hg19: chr18-48586344; COSMIC: COSV61694712; API